Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
about
User-centered research on breast cancer patient needs and preferences of an Internet-based clinical trial matching systemHarnessing information and communication technologies to leverage scarce resources for cancer education, research and practice in developing countries.Clinical Trial Accrual: Obstacles and OpportunitiesRandomized Trial of a Web-Based Intervention to Address Barriers to Clinical TrialsKnowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational model.The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsChallenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendationsDesign-phase prediction of potential cancer clinical trial accrual success using a research data martEffects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial.Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials.Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.Routine data from hospital information systems can support patient recruitment for clinical studies.What leads Indians to participate in clinical trials? A meta-analysis of qualitative studiesExploratory research into cancer patients' attitudes to clinical trialsRecruitment of infants with sickle cell anemia to a Phase III trial: data from the BABY HUG study.State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual.Resolving Rivalries and Realigning Goals: Challenges of Clinical and Research Multiteam Systems.The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Cancer patients' fears related to clinical trial participation: a qualitative study.Does enrollment in cancer trials improve survival?Involving American Indians and medically underserved rural populations in cancer clinical trials.Barriers to participation in cancer prevention clinical trials.Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendationsTiming of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study.Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resourceEffect of a clinical trial alert system on physician participation in trial recruitment.Identifying patient information needs about cancer clinical trials using a Question Prompt ListWillingness to participate in clinical trials among patients of Chinese heritage: a meta-synthesis.Using Personal Health Records for Automated Clinical Trials Recruitment: the ePaIRing ModelEvaluation of patient enrollment in oncology phase I clinical trials.A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies.Trial prospector: matching patients with cancer research studies using an automated and scalable approach.On-line information about cancer clinical trials: evaluating the Web sites of comprehensive cancer centers.Impact of prior cancer on eligibility for lung cancer clinical trials.Feasibility, acceptability and findings from a pilot randomized controlled intervention study on the impact of a book designed to inform patients about cancer clinical trials.Bridging the gap between basic science and clinical practice: the role of organizations in addressing clinician barriers
P2860
Q24682675-D2B9D675-D2E0-4B50-940C-7BB06FF27754Q25256575-25D2E07E-A18C-483D-B0E7-5BCEA67CFF5BQ26747284-DE7AA147-AF25-443F-A557-0CE7CE029B83Q27313405-2E7031B7-DBBC-4309-B3A9-302CA0999873Q30219015-D16873B0-FA6B-4362-AC3C-7BAC60EA373AQ30224746-5634C016-043C-40A0-8065-ABEE55D61D60Q30413922-FDB3F803-9726-4E92-9A59-53328D1F358AQ30424507-06FD2A86-F9EE-4D04-AC36-B2105E486B70Q30557206-5627DA13-CA0E-4CD9-80A9-C9EB822CF98EQ30655148-F2E19730-EF4D-40E0-9774-0E217D03D190Q30665087-F7CB29B6-12B8-40E3-A75D-9F71F8608E81Q30668582-29B221D5-BBC2-470F-9703-563720D27229Q31106969-C9C49F29-F75D-42CE-99DA-3F3938AE4E88Q33263052-EBAE7487-121C-4441-A16E-064FB524971DQ33546278-6BAC03A4-DF32-43DE-B6E0-9A8280BBFE49Q33588531-03202E53-335F-4DCD-A7CC-625DFF36D418Q33636836-E9BCDB51-D2CB-497B-A2BE-BF3997694EF5Q33675632-09FE100D-C07D-4782-8DAF-7238502AAC8FQ33689536-EA77C543-EE90-42AA-A7ED-459B9B3382D7Q33756587-DD2BDD19-CD13-4A88-8CB6-7B947C0BB8C8Q33865329-2F631CB9-0CDB-4A8D-BA86-32244B96B3F6Q33893406-F3F92E7E-183A-40AF-9A87-D1D556D37674Q33895814-40BAB13E-D812-4F2F-B156-1F03C55C69A2Q33936007-F0CDB4B5-B7FC-4709-A79C-E511A6A4078BQ33981798-828E113E-88CC-4C6C-BC27-E0CF0C82C9D2Q34031134-AA3C17B5-6F02-4E49-81C3-3F9F0E412CCBQ34115856-5EE36B5D-9F73-4AAD-B492-24AC1F7C5300Q34209081-94D34253-EAC2-4A74-AFB8-0F02B8214295Q34242249-68FDB8CB-E442-4303-A46D-DD307C97CDB6Q34293754-B609B797-A993-4038-A68C-CECDF6C83D7FQ34297711-51A609BC-8EF8-46F2-B368-287DD4438F56Q34562029-FCF1A23D-959D-467A-B01A-735C0CE120ABQ34585111-192E621D-70FE-4BB4-AA87-EA122A3ECF86Q34594562-A1668B31-9213-4680-8D6D-F512A4EF1C13Q34632541-38E90EBF-1A96-4B97-B1CE-49E88B1A7AF4Q34655304-4E15977B-2556-4623-B7DA-C208D7FB017BQ34686428-95C68C24-4505-4EF0-88F2-DA50B3047A9BQ34736086-4B36C61A-9DB7-4AFD-86EE-C843A5B44207Q34789236-39CCD925-B527-4E71-8538-3694CC2F1CBCQ34916145-A804F9AA-11AA-4817-9103-3574FE3812E0
P2860
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Prospective evaluation of canc ...... ential barriers to enrollment.
@en
type
label
Prospective evaluation of canc ...... ential barriers to enrollment.
@en
prefLabel
Prospective evaluation of canc ...... ential barriers to enrollment.
@en
P2093
P1476
Prospective evaluation of canc ...... ential barriers to enrollment.
@en
P2093
D R Gandara
F J Meyers
P304
P356
10.1200/JCO.2001.19.6.1728
P407
P577
2001-03-01T00:00:00Z